Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
No Image Available

Defibrotide Sodium API Suppliers & Bulk Manufacturers

Available Forms: API (drug substance)

Available Strengths: Supplied to an in-house or pharmacopoeial specification

Reference Brands: Defitelio

Category: Active Pharmaceutical Ingredient

Defibrotide sodium is a mixture of oligonucleotides derived from porcine intestinal DNA, used in an injection for hepatic veno-occlusive disease. Specialist injectable makers and R&D teams source it.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Defibrotide Sodium API? List it or send an offer →

Product Description:

Defibrotide is a mixture of mostly single-stranded oligodeoxyribonucleotides with profibrinolytic properties, helping to restore the balance between clot formation and breakdown in the small blood vessels of the liver. It is approved for adults and children with hepatic veno-occlusive disease, also called sinusoidal obstruction syndrome, after haematopoietic stem-cell transplantation; the US label covers cases with renal or pulmonary dysfunction and the EU label covers severe disease (reference brand: Defitelio).

Specification at a glance

Traded formSodium salts of polydeoxyribonucleotides derived from porcine intestinal tissue; potency is expressed in biological units
CAS number83712-60-1
Molecular weightPolydisperse; mean weighted molecular weight 13–20 kDa (US label)
PharmacopoeiaNo pharmacopoeia monograph found (unverified); supplied to an in-house specification that includes potency by biological assay.

Regulatory files and timing

The FDA list of Drug Master Files (third quarter 2026) shows 0 active Type II API DMFs for this molecule. Few filings usually means few qualified sources, so early contact with suppliers pays off. For Europe, ask whether the supplier holds a CEP or an EU ASMF and, for imports into the EU, a written confirmation.

Generic or biosimilar entry. United States: Patent expiry; entry not confirmed (to 2032 (non-compound patents)). European Union: No confirmed date.

Handling and quality points

As an animal-derived substance, defibrotide needs full traceability of the porcine source, viral safety and TSE documentation, and a clear description of the extraction and depolymerisation process. Quality rests on more than chemical purity: molecular weight distribution, chain composition and biological potency all need to match the reference product, so ask how each is measured. It goes into an injectable, so bioburden, endotoxin and the supplier's controls on microbial quality matter.

Send an API enquiry All specialty APIs

Brand names are trademarks of their respective owners and identify the reference medicine only. Information is general and was checked in October 2026; confirm specifications and filings with the supplier before purchase.

Defibrotide Sodium API — third party manufacturing & bulk supply

Defibrotide Sodium API is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Defibrotide Sodium API is supplied as API (drug substance) — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Defibrotide Sodium API listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Defibrotide Sodium API →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Alongside the GMP certificate and certificate of analysis, buyers ask for animal-origin documentation: source species and country, veterinary health certificates and a TSE statement. Viral inactivation or clearance data, endotoxin and bioburden results, stability data and a DMF or ASMF reference, where one exists, are also standard requests.

It is a heterogeneous mixture rather than a single structure, so sameness has to be shown through molecular weight profile, chain composition and activity in biological assays. Regulators will expect detailed physicochemical and biological comparison with the reference product.

Yes. We match licensed injectable manufacturers, CDMOs and research groups with GMP-compliant producers of complex APIs such as defibrotide, after a first check of their documents. Your details remain private until both sides choose to go ahead.

Related Products

Midostaurin API

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: API (drug substance)

Reference Brands: Rydapt

View Details
Siponimod API

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: API (drug substance)

Reference Brands: Mayzent

View Details
Plecanatide API

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: API (drug substance)

Reference Brands: Trulance

View Details
Pasireotide API

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: API (drug substance)

Reference Brands: Signifor, Signifor LAR

View Details
Elagolix Sodium API

Strength:
USP grade or in-house specification

Form: API (drug substance)

Reference Brands: Orilissa, Oriahnn

View Details
Rilpivirine Hydrochloride API

Strength:
USP grade or in-house specification

Form: API (drug substance)

Reference Brands: Edurant, Complera, Odefsey, Juluca

View Details
Brentuximab Vedotin Drug Substance

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: Drug substance (bulk)

Reference Brands: Adcetris

View Details
Romiplostim Drug Substance

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: Drug substance (bulk)

Reference Brands: Nplate

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us